Equity Overview
Price & Market Data
Price: $33.00
Daily Change: -$0.0808 / 0.24%
Daily Range: $31.75 - $33.64
Market Cap: $1,190,004,224
Daily Volume: 697,489
Performance Metrics
1 Week: -3.65%
1 Month: -21.77%
3 Months: -5.04%
6 Months: -4.16%
1 Year: 92.30%
YTD: 84.65%
Company Details
Employees: 1000
Sector: Health technology
Industry: Medical specialties
Country:
Details
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.